Scientific Papers

Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders | BMC Psychiatry


  • Krausz RM, Westenberg JN, Ziafat K. The opioid Overdose crisis as a global health challenge. Curr Opin Psychiatry. 2021;34(4):405–12.

    Article 
    PubMed 

    Google Scholar
     

  • United Nations. : Office on Drugs and Crime. [cited 2023 Jul 10]. World Drug Report 2021. Available from: https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html.

  • Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010. Drug Alcohol Depend. 2013;132(1–2):95–100.

    Article 
    PubMed 

    Google Scholar
     

  • Abdulrahim D, Bowden-Jones O. The misuse of synthetic opioids: harms and clinical management of fentanyl, fentanyl analogues and other novel synthetic opioids.:32.

  • Death Rate Maps &. Graphs | Drug Overdose | CDC Injury Center. 2022 [cited 2023 May 9]. Available from: https://www.cdc.gov/drugoverdose/deaths/index.html.

  • Sutton P. AF. Provisional Drug Overdose death counts. National Center for Health Statistics; 2023.

  • Understanding the Opioid Overdose Epidemic | Opioids | CDC. 2022 [cited 2023 Jul 10]. Available from: https://www.cdc.gov/opioids/basics/epidemic.html.

  • National Academies of Sciences, Division E H and, Policy M, on HS B, Abuse C on PM and RS to, Phillips APO, Ford JK. MA, Evidence on Strategies for Addressing the Opioid Epidemic. In: Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use. National Academies Press (US); 2017 [cited 2023 Jul 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK458653/.

  • Drogues illicites au Liban. : analyse des politiques et des pratiques. Drogues, santé et société. 2020 [cited 2022 Dec 19]. Available from: https://drogues-sante-societe.ca/drogues-illicites-au-liban-analyse-des-politiques-et-des-pratiques/.

  • Ghandour LA, El Sayed DS, Martins SS. Prevalence and patterns of commonly abused psychoactive prescription Drugs in a sample of University students from Lebanon: an opportunity for cross-cultural comparisons. Drug Alcohol Depend. 2012;121(0):110–7.

    Article 
    PubMed 

    Google Scholar
     

  • Tourbah SG. Report on opioid consumption and number of patients treated. Service Des Stupéfiants, Dpt. De Pharmacie. Lebanon: Ministère de la Santé publique; 2001.

  • Yamout R, Ayoub E, Naccache N, Abou Zeid H, Matar MT, Antakly MC. Opioid Drugs: what is next for Lebanon? J Med Liban. 2013;61(4):210–5.

    PubMed 

    Google Scholar
     

  • Inter-Ministerial Substance Use Response Strategy For. Lebanon 2016–2021. [cited 2023 Jul 10]. Available from: https://www.moph.gov.lb/en/Pages/0/10715/inter-ministerial-substance-use-response-strategy-for-lebanon-2016-2021.

  • Abouzeid M, Habib RR, Jabbour S, Mokdad AH, Nuwayhid I. Lebanon’s humanitarian crisis escalates after the Beirut blast. Lancet Lond Engl. 2020;396(10260):1380–2.

    Article 
    CAS 

    Google Scholar
     

  • El Zouki CJ, Chahine A, Mhanna M, Obeid S, Hallit S. Rate and correlates of post-traumatic stress disorder (PTSD) following the Beirut blast and the economic crisis among Lebanese University students: a cross-sectional study. BMC Psychiatry. 2022;22(1):532.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Solberg KE. Lebanese turn to Drugs to treat mental-health problems. Lancet Lond Engl. 2008;372(9644):1137–8.

    Article 

    Google Scholar
     

  • Noufi P, Khoury E, Ayoub E, Naccache N, Richa S. [Patterns of prescription of opioid analgesics in Hôtel-Dieu De France of Beyrouth]. L’Encephale. 2016;42(6):511–6.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Han B, Compton WM, Blanco C, Jones CM. Correlates of prescription opioid use, Misuse, Use disorders, and motivations for Misuse among US adults. J Clin Psychiatry. 2018;79(5):17m11973.

    Article 
    PubMed 

    Google Scholar
     

  • Singh S, Kumar S, Sarkar S, Balhara YPS. Quality of life and its relationship with Perceived Stigma among Opioid Use Disorder patients: an exploratory study. Indian J Psychol Med. 2018;40(6):556–61.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pierce M, Bird SM, Hickman M, Millar T. National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005–2009. Drug Alcohol Depend. 2015;146:17–23.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med Malden Mass. 2005;6(6):432–42.


    Google Scholar
     

  • Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130(1–2):144–56.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Adams LL, Gatchel RJ, Robinson RC, Polatin P, Gajraj N, Deschner M, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004;27(5):440–59.

    Article 
    PubMed 

    Google Scholar
     

  • WHO ASSIST Working Group. The Alcohol, Smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addict Abingdon Engl. 2002;97(9):1183–94.

    Article 

    Google Scholar
     

  • Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112(1–2):65–75.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain. 2006;7(9):671–81.

    Article 
    PubMed 

    Google Scholar
     

  • Cheatle MD, Compton PA, Dhingra L, Wasser TE, O’Brien CP. Development of the revised Opioid Risk Tool to Predict Opioid Use Disorder in patients with Chronic Non-malignant Pain. J Pain off J Am Pain Soc. 2019;20(7):842–51.

    Article 

    Google Scholar
     

  • Ducharme J, Moore S. Opioid Use Disorder Assessment Tools and Drug Screening. Mo Med. 2019;116(4):318–24.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Miceli L, Bednarova R, Cuomo A, Cascella M, Guardamagna V, Romualdi P et al. Prescribing opioids to patients with chronic pain: translation of the Opioid Risk Tool into Italian. Minerva Anestesiol. 2020;86.

  • Comrey AL, Lee HB. A first course in factor analysis. 2nd ed. New York: Psychology Press; 2013. p. 442.

    Book 

    Google Scholar
     

  • Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989 May 1 [cited 2022 Mar 26];28(2):193–213. Available from: https://www.sciencedirect.com/science/article/pii/0165178189900474.

  • Ch B, Cm AV. M. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul [cited 2022 Mar 26];2(4). Available from: https://pubmed.ncbi.nlm.nih.gov/11438246/.

  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–5.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4(2):97–110.

    CAS 
    PubMed 

    Google Scholar
     

  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • World Health Organization (WHO). (2008) Management of Substance Abuse. The WHO ASSIST Project. WHO, Geneva. http://www.who.int/substance_abuse/activities/assist/en/ – Last accessed: June 2021.

  • Ghandour LA, El Sayed DS, Martins SS. Alcohol and illegal drug use behaviors and prescription opioids use: how do nonmedical and medical users compare, and does motive to use really matter? Eur Addict Res. 2013;19(4):202–10.

    Article 
    PubMed 

    Google Scholar
     

  • Votaw VR, Witkiewitz K, Valeri L, Bogunovic O, McHugh RK. Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders. Addict Behav. 2019;88:48–55.

    Article 
    PubMed 

    Google Scholar
     

  • Smith CS, Reilly C, Midkiff K. Evaluation of three circadian rhythm questionnaires with suggestions for an improved measure of morningness. J Appl Psychol. 1989;74(5):728–38.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bobak CA, Barr PJ, O’Malley AJ. Estimation of an inter-rater intra-class correlation coefficient that overcomes common assumption violations in the assessment of health measurement scales. BMC Med Res Methodol. 2018;18(1):93.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dunn TJ, Baguley T, Brunsden V. From alpha to omega: a practical solution to the pervasive problem of internal consistency estimation. Br J Psychol Lond Engl 1953. 2014;105(3):399–412.


    Google Scholar
     

  • Koo TK, Li MY. A Guideline of selecting and reporting Intraclass correlation coefficients for Reliability Research. J Chiropr Med. 2016;15(2):155–63.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Thorndike RM. Book Review: Psychometric Theory (3rd ed.) by Jum Nunnally and Ira Bernstein New York: McGraw-Hill, 1994, xxiv + 752 pp. Appl Psychol Meas. 1995;19(3):303–5.

  • Schuman-Olivier Z, Hoeppner BB, Weiss RD, Borodovsky J, Shaffer HJ, Albanese MJ. Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes. Drug Alcohol Depend. 2013;132(3):580–6.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ghitza UE, Epstein DH, Preston KL. Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome. Drug Alcohol Depend. 2008;97(1):150–7.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kandel DB, Hu MC, Griesler P, Wall M. Increases from 2002 to 2015 in prescription opioid Overdose deaths in combination with other substances. Drug Alcohol Depend. 2017;178:501–11.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Backmund M, Meyer K, Meyer K, Soyka M, Reimer J, Schütz CG. Co-consumption of benzodiazepines in Heroin users, methadone-substituted and codeine-substituted patients. J Addict Dis. 2006;24(4):17–29.

    Article 

    Google Scholar
     

  • McHugh RK, DeVito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, et al. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013;45(1):38–43.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Eiroa-Orosa FJ, Haasen C, Verthein U, Dilg C, Schäfer I, Reimer J. Benzodiazepine use among patients in heroin-assisted vs. Methadone maintenance treatment: findings of the German randomized controlled trial. Drug Alcohol Depend. 2010;112(3):226–33.

    Article 
    PubMed 

    Google Scholar
     

  • Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, et al. Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States. J Clin Psychiatry. 2016;77(6):772–80.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hser YI, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Huang D. Chronic Pain among patients with opioid use disorder: results from Electronic Health Records Data. J Subst Abuse Treat. 2017;77:26–30.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • McCann-Pineo M, Taioli E, Schwartz RM. Exposure to Hurricane Sandy and risk of opioid abuse. Subst Use Misuse. 2021;56(8):1241–5.

    Article 
    PubMed 

    Google Scholar
     

  • Patel JJ, Volino LR, Cosler LE, Wang X, Kane-Gill SL, Toscani M, et al. Opioid abuse risk among student pharmacists. J Opioid Manag. 2022;18(2):161–6.

    Article 
    PubMed 

    Google Scholar
     

  • Abouzeid M, Halwani DA, Mokdad AH, Habib RR. A generation at risk: the impacts of Lebanon’s Escalating Humanitarian Crisis on children. Front Public Health. 2021;9:704678.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Helou M, El-Hussein M, Aciksari K, Salio F, Della Corte F, von Schreeb J, et al. Beirut Explosion: the largest non-nuclear blast in history. Disaster Med Public Health Prep. 2022;16(5):2200–1.

    Article 
    PubMed 

    Google Scholar
     

  • Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low Use of Opioid Risk Reduction Strategies in Primary Care Even for High Risk Patients with Chronic Pain. J Gen Intern Med. 2011 [cited 2022 May 27];26(9):958–64. https://doi.org/10.1007/s11606-011-1648-2.

  • Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and Clinical Application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006 [cited 2022 May 27];32(3):287–93. Available from: https://www.sciencedirect.com/science/article/pii/S0885392406003472.

  • Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129(3):355–62.

    Article 
    PubMed 

    Google Scholar
     

  • Morasco BJ, Dobscha SK. Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen Hosp Psychiatry. 2008;30(2):93–9.

    Article 
    PubMed 

    Google Scholar
     

  • Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O’Connor PG. Use of Opioid Medications for Chronic Noncancer Pain Syndromes in Primary Care. J Gen Intern Med. 2002 [cited 2022 May 27];17(3):173–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1495018/.

  • AACAP. Alcohol and Drug Abuse. [cited 2022 May 27]. Available from: https://www.aacap.org/aacap/Families_and_Youth/Glossary_of_Symptoms_and_Illnesses/Alcohol_and_Drug_Abuse.aspx.

  • Lander L, Howsare J, Byrne M. The Impact of Substance Use Disorders on Families and Children: From Theory to Practice. Soc Work Public Health. 2013 [cited 2022 Jun 10];28(0):194–205. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725219/.

  • Eshagh Afkari M, Ghasemi A, Shojaeizadeh D, Tol A, Rahimi Foroshani A, Taghdisi MH. Comparison Between Family Function Dimensions and Quality of Life Among Amphetamine Addicts and Non- Addicts. Iran Red Crescent Med J. 2013 [cited 2022 Jun 10];15(4):356–62. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785914/.

  • Kaplan KA, McQuaid J, Batki SL, Rosenlicht N. Behavioral treatment of insomnia in early recovery. J Addict Med. 2014;8(6):395–8.

    Article 
    PubMed 

    Google Scholar
     

  • Weissman MM, Greenwald S, Niño-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry. 1997;19(4):245–50.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39(6):411–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Haario P, Rahkonen O, Laaksonen M, Lahelma E, Lallukka T. Bidirectional associations between insomnia symptoms and unhealthy behaviours. J Sleep Res. 2013;22(1):89–95.

    Article 
    PubMed 

    Google Scholar
     

  • Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following oral THC administration to humans. Psychopharmacology. 1999;141(4):385–94.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Matuskey D, Pittman B, Forselius E, Malison RT, Morgan PT. A multistudy analysis of the effects of early cocaine abstinence on sleep. Drug Alcohol Depend. 2011;115(1–2):62–6.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Peles E, Schreiber S, Adelson M. Variables associated with perceived sleep disorders in Methadone maintenance treatment (MMT) patients. Drug Alcohol Depend. 2006;82(2):103–10.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016 [cited 2022 May 25];11(1):9. https://doi.org/10.1186/s13722-016-0056-7.

  • Irwin MR, Opp MR. Sleep Health: reciprocal regulation of Sleep and Innate Immunity. Neuropsychopharmacol off Publ Am Coll Neuropsychopharmacol. 2017;42(1):129–55.

    Article 
    CAS 

    Google Scholar
     

  • Huhn AS, Finan PH, Gamaldo CE, Hammond AS, Umbricht A, Bergeria CL, et al. Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper. Sci Transl Med. 2022;14(650):eabn8238.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hasler BP, Franzen PL, de Zambotti M, Prouty D, Brown SA, Tapert SF, et al. Eveningness and later sleep timing are Associated with Greater Risk for Alcohol and Marijuana Use in Adolescence: initial findings from the National Consortium on Alcohol and Neurodevelopment in Adolescence Study. Alcohol Clin Exp Res. 2017;41(6):1154–65.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Arrona-Palacios A, Díaz-Morales J, Adan A, Randler C. Sleep habits, circadian preferences and substance use in a Mexican population: the use of the Morningness-Eveningness-Stability-Scale improved (MESSi). Chronobiol Int. 2020;111–22.

  • Goldner EM, Lusted A, Roerecke M, Rehm J, Fischer B. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses. Addict Behav. 2014;39(3):520–31.

    Article 
    PubMed 

    Google Scholar
     

  • Sullivan MD, Edlund MJ, Steffick D, Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119(1–3):95–103.

    Article 
    PubMed 

    Google Scholar
     

  • Langdon KJ, Dove K, Ramsey S. Comorbidity of opioid- and anxiety-related symptoms and disorders. Curr Opin Psychol. 2019;30:17–23.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rosoff DB, Smith GD, Lohoff FW. Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders: A Multivariable Mendelian Randomization Analysis. JAMA Psychiatry. 2021 [cited 2022 May 25];78(2):151–60. https://doi.org/10.1001/jamapsychiatry.2020.3554.

  • Sullivan MD, Edlund MJ, Zhang L, Unützer J, Wells KB. Association Between Mental Health Disorders, Problem Drug Use, and Regular Prescription Opioid Use. Arch Intern Med. 2006 [cited 2022 May 27];166(19):2087–93. https://doi.org/10.1001/archinte.166.19.2087.

  • Klimas J, Gorfinkel L, Fairbairn N, Amato L, Ahamad K, Nolan S, et al. Strategies to identify patient risks of prescription opioid addiction when initiating opioids for Pain: a systematic review. JAMA Netw Open. 2019;2(5):e193365.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Picciotto MR, Brunzell DH, Caldarone BJ. Effect of nicotine and nicotinic receptors on anxiety and depression. NeuroReport. 2002;13(9):1097–106.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wise MH, Weierbach F, Cao Y, Phillips K. Tobacco Use and attachment style in Appalachia. Issues Ment Health Nurs. 2017;38(7):562–9.

    Article 
    PubMed 

    Google Scholar
     

  • Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the Screener and Opioid Assessment for patients with Pain (SOAPP). J Pain Symptom Manage. 2006;32(3):287–93.

    Article 
    PubMed 

    Google Scholar
     

  • Humeniuk R, Henry-Edwards S, Ali R, Poznyak V, Monteiro MG, Organization WH. The Alcohol, Smoking and Substance involvement Screening Test (ASSIST): manual for use in primary care. World Health Organization; 2010 [cited 2021 Oct 28]. Available from: https://apps.who.int/iris/handle/10665/44320.



  • Source link